CRISPR-Cas | The Phage

PhalconBio Secures £1 Million PACE Grant

February 22, 2025

PACE (Pathways to Antimicrobial Clinical Efficacy) is one of the UK’s largest public-private initiatives targeting early-stage antimicrobial medicines and diagnostic discovery. PACE helps to…

Discovery: Dual Functionality of Phage Anti-CRISPR Protein Unveiled

July 10, 2024

Recently published research has made significant strides in understanding the complex interactions between bacteria and the viruses that infect them, known as phages. This…

Study Unveils Viral Resilience Against Bacterial Restriction and Modification Mechanisms

December 12, 2023

In the microscopic battlefield of microbial warfare, bacteriophages emerge as natural adversaries and “predators” of bacteria, demonstrating a remarkable ability to target specific bacterial…

Cell free synthesis of bacteriophages proved more efficient

October 13, 2023

Many people are now familiar with phage therapy, a fascinating approach that harnesses viruses to combat drug-resistant bacteria. While this therapy boasts numerous benefits,…

A bacterium severing phage-antiphage systems

Unveiling the Remarkable Arsenal of Antiphage Defense Systems in Bacteria

July 18, 2023

Did you know that bacteria have developed incredibly diverse and fascinating defense systems to protect themselves against viruses known as phages? These defense mechanisms,…

The Phage

Tag: CRISPR-Cas

PhalconBio Secures £1 Million PACE Grant

Discovery: Dual Functionality of Phage Anti-CRISPR Protein Unveiled

Study Unveils Viral Resilience Against Bacterial Restriction and Modification Mechanisms

Cell free synthesis of bacteriophages proved more efficient

Unveiling the Remarkable Arsenal of Antiphage Defense Systems in Bacteria

Subscribe To Our Weekly Newsletter